Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate safety and tolerability, Pharmacokinetics and
Pharmacodynamics, as well as exploratory efficacy of STP1, in a subgroup of patients with
Autism Spectrum Disorder (ASD).